103 related articles for article (PubMed ID: 15498370)
1. Quantification of plasma DNA as a screening tool for lung cancer.
Xie GS; Hou AR; Li LY; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Oct; 117(10):1485-8. PubMed ID: 15498370
[TBL] [Abstract][Full Text] [Related]
2. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
3. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
4. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
Sozzi G; Conte D; Mariani L; Lo Vullo S; Roz L; Lombardo C; Pierotti MA; Tavecchio L
Cancer Res; 2001 Jun; 61(12):4675-8. PubMed ID: 11406535
[TBL] [Abstract][Full Text] [Related]
5. Cell-surface-bound circulating DNA as a prognostic factor in lung cancer.
Tamkovich SN; Litviakov NV; Bryzgunova OE; Dobrodeev AY; Rykova EY; Tuzikov SA; Zav'ialov AA; Vlassov VV; Cherdyntseva NV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():214-7. PubMed ID: 18837949
[TBL] [Abstract][Full Text] [Related]
6. [Plasma DNA level as a tumor marker in primary lung cancer].
Maebo A
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1085-91. PubMed ID: 2243459
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
Liu L; Liao GQ; He P; Zhu H; Liu PH; Qu YM; Song XM; Xu QW; Gao Q; Zhang Y; Chen WF; Yin YH
Biochem Biophys Res Commun; 2008 Aug; 372(4):756-60. PubMed ID: 18514066
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease.
Zanetti-Dällenbach R; Wight E; Fan AX; Lapaire O; Hahn S; Holzgreve W; Zhong XY
Anticancer Res; 2008; 28(2A):921-5. PubMed ID: 18507037
[TBL] [Abstract][Full Text] [Related]
10. [Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal and gastric cancer].
Tomita H; Ichikawa D; Sai S; Morimura R; Murayama Y; Komatsu S; Ikoma D; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Kokuba Y; Sakakura C; Sonoyama T; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1908-10. PubMed ID: 18219849
[TBL] [Abstract][Full Text] [Related]
11. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
[TBL] [Abstract][Full Text] [Related]
12. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects.
Castagnaro A; Marangio E; Verduri A; Chetta A; D'Ippolito R; Del Donno M; Olivieri D; Di Cola G
Exp Lung Res; 2007 Aug; 33(6):289-301. PubMed ID: 17694439
[TBL] [Abstract][Full Text] [Related]
14. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
Board RE; Williams VS; Knight L; Shaw J; Greystoke A; Ranson M; Dive C; Blackhall FH; Hughes A
Ann N Y Acad Sci; 2008 Aug; 1137():98-107. PubMed ID: 18837931
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.
Szpechcinski A; Struniawska R; Zaleska J; Chabowski M; Orlowski T; Roszkowski K; Chorostowska-Wynimko J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():675-81. PubMed ID: 19218694
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
17. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
Schmidt B; Weickmann S; Witt C; Fleischhacker M
Ann N Y Acad Sci; 2008 Aug; 1137():207-13. PubMed ID: 18837948
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.
Huang ZH; Li LH; Hua D
Cancer Lett; 2006 Nov; 243(1):64-70. PubMed ID: 16412565
[TBL] [Abstract][Full Text] [Related]
19. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?
Schmidt B; Engel E; Carstensen T; Weickmann S; John M; Witt C; Fleischhacker M
Lung Cancer; 2005 Apr; 48(1):145-7. PubMed ID: 15777983
[TBL] [Abstract][Full Text] [Related]
20. DNA integrity in plasma and serum of patients with malignant and benign diseases.
Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
